{
  "source": "PA-Notification-Sucraid.txt",
  "chunks": [
    "UnitedHealthcare Pharmacy\nClinical Pharmacy Programs\nProgram Number 2025 P 1268-7\nProgram Prior Authorization/Notification\nMedication Sucraid (sacrosidase) oral solution\nP&T Approval Date 12/2018, 12/2019, 1/2021, 1/2022, 1/2023, 1/2024, 1/2024\nEffective Date 4/1/2025\n1. Background:\nSucraid (sacrosidase) is an oral enzyme replacement therapy indicated for the treatment of sucrase\ndeficiency, which is part of congenital sucrase-isomaltase deficiency (CSID). The effects of\nSucraid have not been evaluated in patients with secondary (acquired) sucrase deficiency.\n2. Coverage Criteriona:\nA. Initial Authorization\n1. Sucraid will be approved based on the following criterion:\na. Diagnosis of congenital sucrase-isomaltase deficiency.\nAuthorization will be issued for 12 months.\nB. Reauthorization\n1. Sucraid will be approved based on the following criterion:\na. Documentation of positive clinical response to Sucraid therapy.\nAuthorization will be issued for 12 months.\na State mandates may apply. Any federal regulatory requirements and the member specific\nbenefit plan coverage may also impact coverage criteria. Other policies and utilization\nmanagement programs may apply.\n3. Additional Clinical Rules:\n• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-authorization\nbased solely on previous claim/medication history, diagnosis codes (ICD-10) and/or claim logic.\nUse of automated approval and re-approval processes varies by program and/or therapeutic class\n4. References:\n1. Sucraid [package insert]. Vero Beach, FL: QOL Medical, LLC; August 2024.\n© 2025 UnitedHealthcare Services, Inc.\n1\nProgram Prior Authorization/Notification – Sucraid\nChange Control\n12/2018 New program\n12/2019 Annual review, no changes.\n1/2021 Annual review. Updated references.\n1/2022 Annual review with no changes to coverage criteria. Updated\nreference.\n1/2023 Annual review with no changes to coverage criteria. Added state\nmandate footnote and updated reference.\n1/2024 Annual review w",
    "al review with no changes to coverage criteria. Updated\nreference.\n1/2023 Annual review with no changes to coverage criteria. Added state\nmandate footnote and updated reference.\n1/2024 Annual review with no changes to coverage criteria. Updated\nreference.\n1/2025 Annual review with no changes to coverage criteria. Updated\nbackground and reference.\n© 2025 UnitedHealthcare Services, Inc.\n2"
  ]
}